Ultima UG200 picked for 80,000-sample UK Biobank immune study

Ultima Genomics said its UG200 sequencing platform will power a large-scale single-cell immune profiling study with IMU Biosciences and UK Biobank, starting with 80,000 blood samples. The project aims to expand to all 500,000 participants and return the data to UK Biobank for approved researchers and AI research.

• Initial cohort covers 80,000 blood samples, with a goal of all 500,000 participants
• IMU expects over 100 million immune data points per sample
• The project received a £1.57 million Sovereign AI grant
• UG200 launched in February 2026 and is now shipping broadly